BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Oncology News, Insights, Stories by OncoDaily - ECPv6.17.4.1//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Oncology News, Insights, Stories by OncoDaily
X-ORIGINAL-URL:https://oncodaily.com
X-WR-CALDESC:Events for Oncology News, Insights, Stories by OncoDaily
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Halifax
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20250309T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20251102T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20260308T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20261101T050000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0400
TZOFFSETTO:-0300
TZNAME:ADT
DTSTART:20270314T060000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0300
TZOFFSETTO:-0400
TZNAME:AST
DTSTART:20271107T050000
END:STANDARD
END:VTIMEZONE
BEGIN:VTIMEZONE
TZID:Europe/Paris
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20250330T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20251026T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20260329T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20261025T010000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:+0100
TZOFFSETTO:+0200
TZNAME:CEST
DTSTART:20270328T010000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:+0200
TZOFFSETTO:+0100
TZNAME:CET
DTSTART:20271031T010000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260930T120000
DTEND;TZID=America/Halifax:20260930T120000
DTSTAMP:20260803T204029Z
CREATED:20260803T204029Z
LAST-MODIFIED:20260803T204029Z
UID:10000862-1790769600-1790769600@oncodaily.com
SUMMARY:Immune-Related Adverse Events Webinar Series: Pneumonitis - Fred Hutch Cancer Center
DESCRIPTION:The virtual webinar “Immune-Related Adverse Events Webinar Series: Pneumonitis”\, hosted by Fred Hutch Cancer Center\, will take place on 30 September 2026 at 12:00 p.m. PDT via Zoom. \nThe provider-focused session will examine pneumonitis as an adverse effect of immunotherapy\, combining a didactic presentation with 45 minutes of case-based discussion and audience questions. The webinar will be chaired by Shailender Bhatia and Petros Grivas\, with Ajay Sheshadri of The University of Texas MD Anderson Cancer Center joining as the featured expert. The session is designed for clinicians involved in immunotherapy care and offers 1.5 AMA PRA Category 1 Credits™ and 1.8 nursing contact hours.
URL:https://oncodaily.com/event/pneumonitis-558741
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-4-2026-12_38_39-AM.webp
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20260930T183000
DTEND;TZID=America/Halifax:20260930T183000
DTSTAMP:20260826T121258Z
CREATED:20260826T121211Z
LAST-MODIFIED:20260826T121258Z
UID:10000957-1790793000-1790793000@oncodaily.com
SUMMARY:ESMO Guidelines: Real World Cases – Early Stage and Locally Advanced NSCLC 2026
DESCRIPTION:The ESMO Guidelines: Real World Cases Webinar – Early Stage and Locally Advanced NSCLC 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place on September 30\, 2026\, at 6:30 PM CEST (8:30 PM AMT). \nThe webinar will review the latest evidence-based recommendations for early-stage and locally advanced non-small-cell lung cancer (NSCLC)\, with a particular focus on translating the ESMO Clinical Practice Guidelines into everyday clinical decision-making through discussion of a real-world patient case. \nThe expert session is designed to help participants critically assess guideline recommendations\, consider their practical implementation\, and apply current standards of care to multidisciplinary management of patients with potentially curable NSCLC. Participants attending the live webinar can earn 1 ESMO-MORA Category 1 point.
URL:https://oncodaily.com/event/esmo-guidelines-574931
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-26-2026-04_10_40-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261001
DTEND;VALUE=DATE:20261004
DTSTAMP:20260806T151046Z
CREATED:20260806T151029Z
LAST-MODIFIED:20260806T151046Z
UID:10000877-1790812800-1791071999@oncodaily.com
SUMMARY:The IGCS 2026 Annual Global Meeting
DESCRIPTION:The IGCS 2026 Annual Global Meeting\, organized by the International Gynecologic Cancer Society\, will take place on 1–3 October 2026 at the Palais des congrès de Montréal in Montréal\, Canada. \nThe multidisciplinary meeting will bring together specialists in gynecologic surgery\, medical oncology\, radiation oncology\, pathology\, nursing\, research\, and allied healthcare to explore developments across the full spectrum of gynecologic cancer care. The scientific programme will include plenary lectures\, interactive master sessions\, oral and poster presentations\, surgical films\, industry-supported symposia\, exhibitions\, and networking activities. \nTopics will include surgical complications\, artificial intelligence in diagnosis and treatment\, palliative care\, rare gynecologic tumours\, and the translation of emerging research into clinical practice. Attendance is available in person or through on-demand recordings\, with regular registration rates available until 9 September 2026.
URL:https://oncodaily.com/event/igcs-2026-560911
LOCATION:Palais des congrès de Montréal\, 1001 Place Jean-Paul-Riopelle\, Montréal\, Québec\, H2Z 1H5\, Canada
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/IGCS-1.webp
ORGANIZER;CN="International Gynecologic Cancer Society":MAILTO:igcs@igcs.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261001T080000
DTEND;TZID=America/Halifax:20261004T170000
DTSTAMP:20260915T061049Z
CREATED:20260915T061049Z
LAST-MODIFIED:20260915T061049Z
UID:10001025-1790841600-1791133200@oncodaily.com
SUMMARY:28th Annual Lynn Sage Breast Cancer Symposium 2026
DESCRIPTION:The 28th Annual Lynn Sage Breast Cancer Symposium will take place from October 1–4\, 2026\, at the Radisson Blu Aqua Hotel in Chicago\, Illinois\, USA. \nOrganized by the Robert H. Lurie Comprehensive Cancer Center of Northwestern University\, the symposium will bring together experts in medical\, surgical\, and radiation oncology to discuss current advances and multidisciplinary approaches in breast cancer care. Topics will include breast imaging and risk assessment\, pathology\, adjuvant treatment\, advanced disease\, axillary management\, and emerging treatment strategies. \nThis activity has been approved for 22.75 AMA PRA Category 1 Credit(s)™.
URL:https://oncodaily.com/event/breast-cancer-symposium-586257
LOCATION:Radisson Blu Aqua Hotel\, 221 N. Columbus Dr.\, Chicago\, IL\, 60601\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/ChatGPT-Image-Sep-15-2026-10_09_22-AM.webp
ORGANIZER;CN="Robert H. Lurie Comprehensive Cancer Center of Northwestern University":MAILTO:cancer@northwestern.edu
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261001T120000
DTEND;TZID=America/Halifax:20261001T133000
DTSTAMP:20260902T165901Z
CREATED:20260902T165901Z
LAST-MODIFIED:20260902T165901Z
UID:10000986-1790856000-1790861400@oncodaily.com
SUMMARY:GUPS Virtual Education Series: Bridges in Genitourinary Oncology
DESCRIPTION:The “Bridges in Genitourinary Oncology – From Pathology Phenotypes to Clinical Realities” webinar\, organized by the Genitourinary Pathology Society (GUPS)\, will take place on October 1\, 2026\, from 12:00 PM to 1:30 PM ET (8:00 PM to 9:30 PM AMT) as a live virtual webinar via Zoom. \nThe session will connect pathologic findings with their clinical implications across genitourinary oncology. Ting Zhao will discuss the molecular underpinnings and clinical significance of cribriform\, intraductal\, and ductal prostate cancer; Swati Bhardwaj will review gynecologic tumors and tumor-like lesions involving the genitourinary system; and Gabriela M. Quiroga-Garza will present recent clinicopathologic updates on aggressive urothelial carcinoma subtypes. \nThe webinar will be moderated by Aiman Haider\, Cornelia Ding\, and Rohit Mehra. GUPS has also publicly confirmed the October 1 session and its 90-minute schedule.
URL:https://oncodaily.com/event/genitourinary-oncology-579612
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/IMG_1811-800x439-1-1.webp
ORGANIZER;CN="Genitourinary Pathology Society":MAILTO:desk@gups.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261002
DTEND;VALUE=DATE:20261003
DTSTAMP:20260822T140005Z
CREATED:20260822T140005Z
LAST-MODIFIED:20260822T140005Z
UID:10000942-1790899200-1790985599@oncodaily.com
SUMMARY:Transforming Pediatric and Young Adult Brain and Spine Tumor Care Through Multidisciplinary Innovation
DESCRIPTION:The Transforming Pediatric and Young Adult Brain and Spine Tumor Care Through Multidisciplinary Innovation symposium\, presented by the Memorial Sloan Kettering Cancer Center (MSK) Department of Neurosurgery and MSK Kids\, will take place virtually on October 2\, 2026. \nThe program will provide a multidisciplinary overview of pediatric brain and spinal tumor care\, bringing together experts in pediatric neuro-oncology\, neurosurgery\, radiation oncology\, neuropathology and molecular diagnostics\, rehabilitation medicine\, and neuropsychology. \nTopics will include molecularly guided diagnosis\, innovative surgical approaches\, emerging targeted therapies and clinical trials\, precision radiation strategies\, rehabilitation and functional recovery\, and long-term neurocognitive outcomes. \nFaculty will also highlight specialized MSK Kids programs\, including the Adolescent and Young Adult Oncology Program\, Pediatric Translational Medicine Program\, Neurofibromatosis Program\, and Retinoblastoma Program. Participants can attend the live Zoom webinar or access the recorded program on demand afterward. \nThe activity offers up to 4.50 AMA PRA Category 1 Credits™\, along with eligible MOC credits/points; nursing contact hours are pending. Registration is free for all participants.
URL:https://oncodaily.com/event/brain-and-spine-tumor-572282
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-22-2026-05_58_05-PM.webp
ORGANIZER;CN="Memorial Sloan Kettering Cancer Center (MSK)":MAILTO:international@mskcc.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261002
DTEND;VALUE=DATE:20261004
DTSTAMP:20260303T101152Z
CREATED:20260303T101152Z
LAST-MODIFIED:20260303T101152Z
UID:10000680-1790899200-1791071999@oncodaily.com
SUMMARY:2026 International Symposium of Gastrointestinal Oncology (ISGIO)
DESCRIPTION:The 2026 International Symposium of Gastrointestinal Oncology (ISGIO)\, hosted by Physicians’ Education Resource\, LLC\, will be held from October 2–3\, 2026\, at the W Fort Lauderdale in Florida. This premier two-day multidisciplinary conference is dedicated to the latest breakthroughs in gastrointestinal (GI) cancer research and the evolving treatment landscape. Led by program co-chairs Dr. Tanios Bekaii-Saab and Dr. Eileen M. O’Reilly\, the symposium utilizes case-based learning\, expert debates\, and panel discussions to help clinicians navigate complex clinical trial data and translate emerging evidence into personalized patient care. \nRegister now.
URL:https://oncodaily.com/event/gastrointestinal-oncology-463751
LOCATION:W Fort Lauderdale\, 401 North Fort Lauderdale Beach Boulevard\, Fort Lauderdale\, FL\, 33304\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/03/BeFunky-collage-2026-03-03T141114.437.webp
ORGANIZER;CN="Physicians' Education Resource":MAILTO:onc-info@gotoper.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261002
DTEND;VALUE=DATE:20261004
DTSTAMP:20260721T160010Z
CREATED:20260721T160010Z
LAST-MODIFIED:20260721T160010Z
UID:10000811-1790899200-1791071999@oncodaily.com
SUMMARY:ESMO Advanced Course on Precision Treatment Sequencing in Metastatic Breast Cancer 2026
DESCRIPTION:The ESMO Advanced Course on Precision Treatment Sequencing in Metastatic Breast Cancer 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place on 2–3 October 2026 in Singapore. \nThe course will focus on treatment sequencing\, the biology of metastatic breast cancer\, targeted therapy safety and adverse-event management\, and multidisciplinary approaches to improving patient outcomes. Applications close on 21 August 2026 at 23:59 CEST. Non-local participants may receive a travel grant of up to €600\, and the programme is accredited with 10 ESMO-MORA Category 1 points. \nApply Now.
URL:https://oncodaily.com/event/metastatic-breast-cancer-2026-547927
LOCATION:Singapore\, Republic of Singapore
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-21-2026-07_50_11-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261002
DTEND;VALUE=DATE:20261004
DTSTAMP:20260721T161206Z
CREATED:20260721T161206Z
LAST-MODIFIED:20260721T161206Z
UID:10000812-1790899200-1791071999@oncodaily.com
SUMMARY:ESMO Advanced Course on Optimising Treatment Sequencing in Advanced NSCLC
DESCRIPTION:The ESMO Advanced Course on Optimising Treatment Sequencing in Advanced NSCLC 2026\, oorganized by the European Society for Medical Oncology (ESMO)\, will take place on 2–3 October 2026 in Singapore. \nThe course will focus on sequencing strategies for actionable genomic alteration-positive NSCLC\, biomarker-driven treatment using NGS\, immunohistochemistry\, and liquid biopsy\, and emerging therapies such as antibody–drug conjugates\, bispecific antibodies\, cellular therapies\, and vaccines. It will also address multidisciplinary management of oligometastatic disease and brain metastases. Applications close on 10 August 2026 at 23:59 CEST\, and non-local participants may receive a travel grant of up to €600. \nApply Now.
URL:https://oncodaily.com/event/advanced-nsclc-547940
LOCATION:Singapore\, Republic of Singapore
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-21-2026-08_06_59-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261002
DTEND;VALUE=DATE:20261004
DTSTAMP:20260909T195429Z
CREATED:20260909T195429Z
LAST-MODIFIED:20260909T195429Z
UID:10001003-1790899200-1791071999@oncodaily.com
SUMMARY:4th Tanzania International Cancer Conference (TICC 2026)
DESCRIPTION:The 4th Tanzania International Cancer Conference (TICC 2026)\, organized by the Tanzania Oncology Society (TOS)\, will take place on October 2–3\, 2026\, at Hyatt Regency Dar es Salaam\, The Kilimanjaro\, in Dar es Salaam\, Tanzania. \nThe conference will bring together oncologists\, researchers\, physicians\, nurses\, policymakers\, and other cancer-care stakeholders to discuss challenges and opportunities in improving cancer care in Tanzania. \nThe programme is expected to address areas including cancer prevention and control\, diagnosis\, treatment and care\, cancer research\, palliative care\, and survivorship\, while providing a platform for professional exchange\, collaboration\, and discussion of practical approaches to strengthening oncology services. The Tanzania Oncology Society’s current homepage identifies the meeting as the 4th TICC and confirms the October 2–3 dates.
URL:https://oncodaily.com/event/tanzania-international-cancer-conference-583522
LOCATION:Hyatt Regency Dar es Salaam\, The Kilimanjaro\, 24 Kivukoni Front\, Dar es Salaam\, Dar es Salaam Region\, Tanzania\, United Republic of
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/ChatGPT-Image-Sep-9-2026-11_51_15-PM.webp
ORGANIZER;CN="Tanzania Oncology Society":MAILTO:tanzaniaoncologysociety@gmail.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261002
DTEND;VALUE=DATE:20261004
DTSTAMP:20260909T202849Z
CREATED:20260909T202849Z
LAST-MODIFIED:20260909T202849Z
UID:10001004-1790899200-1791071999@oncodaily.com
SUMMARY:WIN Symposium 2026: Precision Oncology - Innovation and Equity Across the Globe
DESCRIPTION:The WIN Symposium 2026: Precision Oncology – Innovation and Equity Across the Globe\, organized by the Worldwide Innovative Network (WIN) Consortium in Personalized Cancer Medicine\, will take place on October 2–3\, 2026\, at the Rhode Island Convention Center in Providence\, Rhode Island\, USA. \nThe two-day international meeting will bring together clinicians\, researchers\, data scientists\, regulators\, industry representatives\, and patient advocates to discuss advances in precision oncology and their implementation in clinical practice. \nThe programme will cover genomics\, translational science\, immunotherapy\, radiation oncology\, artificial intelligence\, cancer informatics\, biomarker-driven care\, novel therapeutics\, innovative clinical trial designs\, and equitable access to precision medicine\, with plenary lectures\, interactive panels\, fireside chats\, Q&A sessions\, and a multidisciplinary molecular tumor board.
URL:https://oncodaily.com/event/win-symposium-2026-583541
LOCATION:Rhode Island Convention Center\, 1 Sabin Street\, Providence\, RI\, 02903\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/ChatGPT-Image-Sep-10-2026-12_23_42-AM.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261002
DTEND;VALUE=DATE:20261005
DTSTAMP:20251226T221942Z
CREATED:20251226T221928Z
LAST-MODIFIED:20251226T221942Z
UID:10000532-1790899200-1791158399@oncodaily.com
SUMMARY:29th British Oncology Pharmacy Association (BOPA) Annual Conference
DESCRIPTION:The 29th British Oncology Pharmacy Association (BOPA) Annual Conference is a key scientific meeting for oncology pharmacy professionals\, scheduled for October 2–4\, 2026\, at the ICC London Olympia. \nThe symposium focuses on the technical and clinical advancements in cancer pharmacy\, featuring a peer-reviewed scientific program that covers therapeutic updates\, service delivery innovation\, and clinical research in oncology.
URL:https://oncodaily.com/event/british-oncology-pharmacy-association-434589
LOCATION:ICC London Olympia\, Hammersmith Rd\, London\, Greater London\, W14 8UX\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2025/12/BOPA.webp
ORGANIZER;CN="British Oncology Pharmacy Association (BOPA)":MAILTO:membership@bopa.org.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261002T090000
DTEND;TZID=America/Halifax:20261002T170000
DTSTAMP:20260806T134329Z
CREATED:20260806T134329Z
LAST-MODIFIED:20260806T134329Z
UID:10000874-1790931600-1790960400@oncodaily.com
SUMMARY:The 19th Annual Royal Marsden Breast Cancer Meeting
DESCRIPTION:The 19th Annual Royal Marsden Breast Cancer Meeting: Hot Topics in Breast Cancer\, organized by The Royal Marsden NHS Foundation Trust\, will take place on 2 October 2026 in London\, United Kingdom. \nThe meeting will bring together the multidisciplinary breast cancer care team for education\, clinical updates\, and discussion of emerging innovations. The programme will cover decision-making in early ER-positive breast cancer\, including molecular testing\, endocrine therapy options\, and symptom management\, alongside developments in radiation oncology\, 3D surgical imaging\, and psychological support. International keynote speaker Cristina Saura from Vall d’Hebron University Hospital in Spain will discuss advances in HER2-targeted therapy. \nThe meeting will conclude with an interactive multidisciplinary team case discussion and is open to clinicians and senior nurses involved in breast cancer care.
URL:https://oncodaily.com/event/royal-marsden-breast-cancer-560832
LOCATION:Royal College of Physicians\, 11 St Andrews Place\, Regent’s Park\, London\, Greater London\, NW1 4LE\, United Kingdom
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/Royal-Marsden-meeting.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261003
DTEND;VALUE=DATE:20261004
DTSTAMP:20260816T152759Z
CREATED:20260816T152759Z
LAST-MODIFIED:20260816T152759Z
UID:10000919-1790985600-1791071999@oncodaily.com
SUMMARY:The Multidisciplinary GI Oncology Summit 2026
DESCRIPTION:The Multidisciplinary GI Oncology Summit 2026: Advances in Gastrointestinal Cancer Care\, Biomarkers\, and Team-Based Treatment Strategies\, organized by Binaytara\, will take place on October 3\, 2026 at the Hilton Columbus Downtown in Columbus\, Ohio. \nThis one-day CME/CE-accredited conference will bring together specialists in medical oncology\, surgical oncology\, radiation oncology\, gastroenterology\, pathology\, radiology\, pharmacy\, nursing\, and multidisciplinary cancer care to review evidence-based advances in the diagnosis and management of gastrointestinal malignancies. \nThe program will emphasize collaborative\, team-based care and include multidisciplinary discussions on current clinical practice\, emerging biomarkers\, recent treatment advances\, and areas of unmet research need that may inform future drug development. \nThe meeting is co-chaired by Brent Xia\, MD\, FACS\, FSSO\, of St. Elizabeth Healthcare\, and Ibrahim Sahin\, MD\, of the University of Michigan\, and is designed for physicians\, advanced practice providers\, pharmacists\, nurses\, and other professionals involved in GI cancer care.
URL:https://oncodaily.com/event/gi-oncology-summit-567770
LOCATION:Hilton Columbus Downtown\, 402 North High Street\, Columbus\, OH\, 43215\, United States
ATTACH;FMTTYPE=image/avif:https://oncodaily.com/pub/uploads/2026/08/public.avif
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261003
DTEND;VALUE=DATE:20261006
DTSTAMP:20260804T174123Z
CREATED:20260804T174123Z
LAST-MODIFIED:20260804T174123Z
UID:10000865-1790985600-1791244799@oncodaily.com
SUMMARY:The 14th International Symposium on Hodgkin Lymphoma (ISHL14)
DESCRIPTION:The 14th International Symposium on Hodgkin Lymphoma (ISHL14)\, organized by the German Hodgkin Study Group (GHSG) at University Hospital Cologne\, will take place on 3–5 October 2026 in Cologne\, Germany. \nThe symposium will provide a comprehensive overview of the latest advances in Hodgkin lymphoma biology\, diagnostics\, clinical research\, and treatment. It will be chaired by Peter Borchmann\, with Paul J. Bröckelmann\, Dennis Eichenauer\, and Justin Ferdinandus serving as symposium co-chairs. The programme is accredited by the European Board for Accreditation in Hematology and offers 16 EBAH CME points.
URL:https://oncodaily.com/event/hodgkin-lymphoma-559340
LOCATION:Gürzenich Cologne\, Martinstraße 29–37\, Cologne\, North Rhine-Westphalia\, 50667\, Germany
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/Upload-ishl14-banner-generic-jpg-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261003T080000
DTEND;TZID=America/Halifax:20261003T160000
DTSTAMP:20260816T200037Z
CREATED:20260816T200037Z
LAST-MODIFIED:20260816T200037Z
UID:10000923-1791014400-1791043200@oncodaily.com
SUMMARY:The Best of Lung Cancer 2026
DESCRIPTION:The Best of Lung Cancer 2026\, organized by the Innovative Healthcare Institute (IHCI)\, will take place on October 3\, 2026\, from 8:00 AM to 4:00 PM ET at the Holiday Inn Cincinnati – Liberty Way by IHG in West Chester\, Ohio. \nThis CME-certified\, case-based educational conference will bring together nationally recognized experts and healthcare professionals involved in lung cancer care to review recent advances in diagnosis\, molecular profiling\, and treatment. \nThe programme will cover biomarker testing\, tissue and liquid biopsy\, perioperative strategies for NSCLC\, updates from ASCO and WCLC\, antibody-drug conjugates\, and targeted therapies for alterations including EGFR\, ALK\, ROS1\, MET\, KRAS\, HER2\, RET\, and NTRK. Interactive case presentations and expert panel discussions will focus on translating emerging evidence into practical clinical decision-making. \nThe conference is designed for medical and radiation oncologists\, thoracic surgeons\, pulmonologists\, pathologists\, advanced practice providers\, pharmacists\, nurses\, and other professionals involved in thoracic oncology.
URL:https://oncodaily.com/event/best-of-lung-cancer-567923
LOCATION:Holiday Inn Cincinnati – Liberty Way by IHG\, 7500 Tylers Place Boulevard\, West Chester\, OH\, 45069\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/1784230565360-800x420-1.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261005
DTEND;VALUE=DATE:20261007
DTSTAMP:20260607T150448Z
CREATED:20260607T150448Z
LAST-MODIFIED:20260607T150448Z
UID:10000740-1791158400-1791331199@oncodaily.com
SUMMARY:2026 NCCN 2-Day Fall Policy Summit
DESCRIPTION:The 2026 NCCN 2-Day Fall Policy Summit is scheduled for Monday\, October 5 – Tuesday\, October 6\, 2026\, at the National Press Club in Washington\, D.C. \nThe event features a new two-day format with options to attend virtually or in person\, gathering patients\, providers\, payers\, policymakers\, advocates\, and industry leaders to discuss the current landscape of cancer screening and prevention services. The summit will explore population- and individual-level advancements\, current infrastructure capabilities for high-risk populations\, and policy-level challenges\, including the role of USPSTF guidelines and efforts to reduce cost barriers for diagnostic services. Key topics will also feature disparities in screening\, infrastructure funding\, emerging innovations like AI and blood-based tests\, and initiatives aligned with the Trump Administration’s Make America Healthy Again agenda. \nRegister Now.
URL:https://oncodaily.com/event/nccn-516756
LOCATION:National Press Club in Washington\, D.C\, 529 14th St NW\, Washington\, DC 20045\, Washington
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/06/BeFunky-collage-2026-06-07T190215.141.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261005
DTEND;VALUE=DATE:20261007
DTSTAMP:20260801T192530Z
CREATED:20260801T192530Z
LAST-MODIFIED:20260801T192530Z
UID:10000849-1791158400-1791331199@oncodaily.com
SUMMARY:The 2nd Annual GCRIS 2026
DESCRIPTION:The 2nd Annual Global Cancer Research & Innovation Symposium (GCRIS 2026)\, sponsored by the Association of Value-Based Cancer Care (AVBCC)\, will take place on 5–6 October 2026 in New York City under the theme “Accelerating Tomorrow’s Cancer Breakthroughs Through Investment and Leading-Edge Science.” \nThe 1.5-day symposium will connect investors\, biotechnology and pharmaceutical leaders\, academic researchers\, cancer centres\, regulators\, and clinical partners across the oncology drug-development lifecycle. \nDay one will examine the intersection of science and capital\, including investment trends\, emerging research\, and policy changes\, while day two will focus on innovative therapies\, regulatory pathways\, artificial intelligence in drug discovery\, and strategies for accelerating promising products into patient care. The programme will also include networking opportunities and presentations from start-up researchers and young investigators supported by Swim Across America.
URL:https://oncodaily.com/event/gcris-557071
LOCATION:New York Athletic Club\, 180 Central Park South\, New York\, NY\, 10019\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/image001.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261005
DTEND;VALUE=DATE:20261007
DTSTAMP:20260915T090721Z
CREATED:20260915T090721Z
LAST-MODIFIED:20260915T090721Z
UID:10001026-1791158400-1791331199@oncodaily.com
SUMMARY:CDDF and EORTC Joint Workshop on Health Technology Assessment in Cancer Drug Development
DESCRIPTION:The CDDF & EORTC Joint Workshop on Health Technology Assessment in Cancer Drug Development will take place on October 5–6\, 2026\, at the Cardo Hotel Brussels in Brussels\, Belgium\, with online participation available. \nJointly organized by the Cancer Drug Development Forum (CDDF) and European Organisation for Research and Treatment of Cancer (EORTC)\, the workshop will bring together experts from academia\, regulatory authorities\, HTA agencies\, patient organizations\, and other stakeholders to discuss evidence generation\, assessment methodologies\, implementation of HTA regulation\, and future innovation in cancer drug development.
URL:https://oncodaily.com/event/eortc-586299
LOCATION:Cardo Hotel Brussels\, Avenue du Boulevard 14\, Brussels\, Brussels-Capital Region\, 1210\, Belgium
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/ChatGPT-Image-Sep-15-2026-01_06_13-PM.webp
ORGANIZER;CN="Cancer Drug Development Forum":MAILTO:info@cddf.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261005
DTEND;VALUE=DATE:20261008
DTSTAMP:20260323T191952Z
CREATED:20260323T110020Z
LAST-MODIFIED:20260323T191952Z
UID:10000709-1791158400-1791417599@oncodaily.com
SUMMARY:Global Cardio-Oncology Summit (GC-OS) 2026
DESCRIPTION:The 2026 Global Cardio-Oncology Summit (GC-OS) will be held from October 5–7\, 2026\, in Williamsburg\, Virginia.  \nHosted by the International Cardio-Oncology Society (IC-OS)\, this premier interdisciplinary event is centered on the theme “Cardio-Oncology Innovation and Implementation for the Future.” It serves as a global platform for cardiologists\, oncologists\, and researchers to address the cardiovascular challenges faced by cancer survivors. \nThe scientific program focuses on cutting-edge clinical frontiers\, including the integration of artificial intelligence in diagnostics\, new treatments for cardiac amyloidosis\, and the role of the immune system in cardiovascular health. Key sessions will cover multimodality cardiac imaging\, next-generation therapies in hematology\, and evidence-based exercise interventions designed to mitigate cardio-toxicity. \nBeyond the core lectures\, the summit emphasizes global networking and early-career development through the Young Investigator Award competition on October 7. Set in the historic Williamsburg Inn\, the event balances rigorous academic exchange with the cultural backdrop of one of the U.S.’s most significant historical sites\, providing an ideal environment for professional collaboration and the presentation of original research.
URL:https://oncodaily.com/event/cardio-oncology-473405
LOCATION:Williamsburg Inn\, 136 Francis St E\, Williamsburg\, VA\, 23185\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/03/BeFunky-collage-2026-03-23T145341.350.webp
ORGANIZER;CN="International Cardio-Oncology Society (IC-OS)":MAILTO:StephenCasselli@ic-os.org
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261005
DTEND;VALUE=DATE:20261009
DTSTAMP:20260609T080948Z
CREATED:20260608T204856Z
LAST-MODIFIED:20260609T080948Z
UID:10000756-1791158400-1791503999@oncodaily.com
SUMMARY:The 16th World Clinical Biomarkers and Companion Diagnostics Summit
DESCRIPTION:The landmark World Clinical Biomarkers & Companion Diagnostics Summit returns to Boston at a pivotal moment for precision medicine. With rapid advances in genomic testing\, companion diagnostics\, digital pathology\, spatial omics\, multimodal analytics\, and AI-enabled platforms\, the summit will bring together more than 850 senior stakeholders across biopharma\, diagnostics\, regulatory\, healthcare\, CRO\, testing lab\, and technology communities to accelerate drug-diagnostic innovation and improve patient access to precision care. \nEvent Name: 16th World Clinical Biomarkers & Companion Diagnostics Summit  \nEvent Date: October 5-8\, 2026 \nEvent Venue: The Westin Boston Seaport District\, 425 Summer Street\, Boston\, MA 02210 \nRecent regulatory shifts\, followed by a surge in Rx-Dx launches\, expanded access in advanced genomic testing\, rapid innovation in digital pathology\, spatial omics\, multimodal analytics and agentic AI diagnostic platforms\, alongside sustained\, sizeable investments\, signal that precision medicine is entering a defining new era. \nIt is in this context that the 16th World Clinical Biomarkers & Companion Diagnostics Summit returns to Boston\, as your longest-standing definitive forum uniting the complete precision medicine ecosystem. Boasting an audience of 850+ senior stakeholders from biopharma\, diagnostic\, regulatory\, healthcare\, CRO\, testing labs and multimodal communities\, this remains the place to strengthen and build the necessary collaborations to accelerate drug-diagnosti  innovations from bench to bedside. \nBe the first to see the newly released 4-day program. \nTo reflect the complex nature and rapid acceleration of novel endpoints and IVD advances\, this year’s meeting will expand to five dedicated content tracks. \n\nBiomarker Discovery & Translation: Equip your translation development\, biomarker discovery\, biomarker operations and oncology teams with the insights needed to validate novel\, highly translatable biomarker panels for both solid tissue and liquid biopsy diagnostic strategies.\nClinical & CDx Development: Aimed at clinical development\, medical affairs\, CDx development\, strategic partnerships and regulatory teams\, this content will provide you with the toolkit to deliver compliant clinical trials\, enrolment and monitoring workflows.\nRx-Dx Commercialization & Adoption: Provide your pricing\, reimbursement\, market access\, HOER and commercialization teams with access to the latest industry shifts and international payer evidence needs\, to ensure rapid synchonrised\, global adoption.\nDigital Pathology & Spatial Biomarkers: Designed for digital pathology\, imaging\, spatial biology and CDx development teams\, this new track will dive into best-in- class ways to standardize analysis\, boost throughput and improve reproducibility.\nMultimodal & AI-Enabled Precision Medicine: Offer your data science\, RWE\, AI & analytics and digital innovation teams\, the chance to hear the cutting-edge data driving and ML-enabled biomarker discovery\, clinical insights\, and precision endpoints.\n\nConvene with peers\, benchmark strategies\, forge new connections\, stay informed on the latest industry trends and streamline your co development pipeline\, at the industry’s leading touchpoint for precision medicine professionals. \nTogether let’s bring accessible\, affordable precision healthcare to patients quicker. \nAttendance is free* for drug developers and researchers. \n*Subject to eligibility and Ts and Cs: visit the website to learn more.
URL:https://oncodaily.com/event/16th-world-clinical-biomarkers-517593
LOCATION:The Westin Boston Seaport District\, 425 Summer Street\, Boston\, MA 02210\, The Westin Boston Seaport District\, 425 Summer Street\, Boston\, MA\, 02210\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/06/OncoDiaily.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261006
DTEND;VALUE=DATE:20261009
DTSTAMP:20251117T110913Z
CREATED:20251117T110848Z
LAST-MODIFIED:20251117T110913Z
UID:10000365-1791244800-1791503999@oncodaily.com
SUMMARY:EACR Conference on Cancer Metabolism
DESCRIPTION:The European Association for Cancer Research (EACR) Conference on Cancer Metabolism will be held in Bilbao\, Spain\, from October 6–8\, 2026. This conference focuses on metabolic reprogramming\, a key hallmark of tumors\, and the metabolic alterations that cancer and stromal cells undergo to meet energetic demands\, survive in hostile environments\, and modify their niche. \nThe meeting will gather top experts to discuss the mechanisms through which metabolites regulate cell decisions\, the metabolic interaction between the tumor and the host\, and explore undocumented metabolic alterations in cancer. It targets basic and translational scientists and clinicians\, aiming to provide a broad and detailed overview of the most recent advances in the field. \nRegister.
URL:https://oncodaily.com/event/eacr-411028
LOCATION:The Euskalduna Conference Centre\, Abandoibarra Etorb.\, 4\, Abando\, Bilbao\, Bizkaia\, 48011\, Spain
ATTACH;FMTTYPE=image/jpeg:https://oncodaily.com/pub/uploads/2025/11/WhatsApp-Image-2025-11-17-at-15.06.47.jpeg
ORGANIZER;CN="European Association for Cancer Research":MAILTO:jane.smith@eacr.org
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=Europe/Paris:20261006T000000
DTEND;TZID=Europe/Paris:20261008T153000
DTSTAMP:20260221T093949Z
CREATED:20260221T093949Z
LAST-MODIFIED:20260221T093949Z
UID:10000657-1791244800-1791473400@oncodaily.com
SUMMARY:The Early Detection of Cancer Conference 2026
DESCRIPTION:The Early Detection of Cancer Conference 2026 is set to convene from October 6–8 at the Edinburgh International Conference Centre (EICC) in Scotland.  \nCo-hosted by Cancer Research UK and the OHSU Knight Cancer Institute\, this premier three-day summit serves as a global focal point for the International Alliance for Cancer Early Detection (ACED). \nThe program is designed to transcend traditional research presentations\, featuring high-stakes “Great Debates” and multidisciplinary panels that bridge the gap between discovery biology and clinical implementation. Bringing together a diverse community of scientists\, clinicians\, and industry leaders\, the 2026 meeting will prioritize the translation of cutting-edge technologies—including AI-driven diagnostics and multi-cancer early detection (MCED) tests—into equitable healthcare solutions aimed at identifying cancer at its most treatable stages.
URL:https://oncodaily.com/event/cancer-458938
LOCATION:Edinburgh International Conference Centre (EICC)\, 150 Morrison St\, Edinburgh\, EH3 8EE
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/02/BeFunky-collage-2026-02-21T134019.723.webp
ORGANIZER;CN="Cancer Research UK":MAILTO:supporter.services@cancer.org.uk
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261006T160000
DTEND;TZID=America/Halifax:20261006T170000
DTSTAMP:20260820T134710Z
CREATED:20260820T134710Z
LAST-MODIFIED:20260820T134710Z
UID:10000938-1791302400-1791306000@oncodaily.com
SUMMARY:Target Engagement and AutoTSA in Small Molecule Drug Discovery - Oncode Accelerator
DESCRIPTION:The Building Bridges: Target Engagement Profiling & AutoTSA for Small Molecule Drug Discovery webinar\, organized by Oncode Accelerator\, will take place on October 6\, 2026\, from 4:00 PM to 5:00 PM CET via Microsoft Teams. \nThe webinar will explore two complementary approaches to reducing risk in early-stage oncology drug development\, with a focus on small molecules. Jennifer McCormack-Venhorst\, PhD\, Senior Scientist Integrator at TNO\, will present AutoTSA: Faster Target Safety Decisions for Drug Discovery\, highlighting an AI-driven approach that uses generative AI and large language model-based tools to support automated target safety assessments while maintaining human oversight. \nAnthe Janssen\, PhD\, Assistant Professor at Leiden University and Co-founder and CSO of Omivera\, will discuss target engagement profiling using chemical proteomics and the CellEKT platform\, which measures investigational compound interactions across a broad range of kinase and non-kinase targets in living-cell systems. Together\, the presentations will examine how AI-enabled safety assessment and in-cell target engagement profiling can help accelerate and de-risk small-molecule discovery programs.
URL:https://oncodaily.com/event/small-molecule-drug-discovery-570693
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/1784019584168.webp
ORGANIZER;CN="Oncode Accelerator":MAILTO:: info@oncodeaccelerator.nl
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261006T171500
DTEND;TZID=America/Halifax:20261006T183000
DTSTAMP:20260901T202042Z
CREATED:20260901T202042Z
LAST-MODIFIED:20260901T202042Z
UID:10000978-1791306900-1791311400@oncodaily.com
SUMMARY:The MOS 2026 Fall Conference
DESCRIPTION:The MOS 2026 Fall Conference\, organized by the Missouri Oncology Society (MOS)\, will take place on October 6\, 2026\, from 5:15 PM to 8:30 PM CT\, at Le Méridien St. Louis Clayton in Clayton\, Missouri. \nThe in-person evening conference will bring together oncology professionals from across Missouri for education\, networking\, dinner\, and discussion focused on advancing cancer care. The programme will address local healthcare disparities\, emerging therapies\, practice-management challenges\, and practical strategies to improve patient outcomes\, while also creating opportunities for collaboration among oncology professionals and industry partners.
URL:https://oncodaily.com/event/mos-2026-fall-conference-579115
LOCATION:Le Méridien St. Louis Clayton\, 7730 Bonhomme Avenue\, Clayton\, MO\, 63105\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/09/ChatGPT-Image-Sep-2-2026-12_19_50-AM.webp
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261006T180000
DTEND;TZID=America/Halifax:20261006T190000
DTSTAMP:20260724T121622Z
CREATED:20260724T121501Z
LAST-MODIFIED:20260724T121622Z
UID:10000819-1791309600-1791313200@oncodaily.com
SUMMARY:SPCC Webinar 2026: How Supportive Care Can Improve Cancer Survival
DESCRIPTION:The live webinar “Supportive Care Enhances Patient Survival”\, organized by Sharing Progress in Cancer Care (SPCC)\, will take place on 6 October 2026 from 18:00 to 19:00 CEST\, with CME accreditation in progress. \nThe session will explore how exercise\, nutrition\, symptom management\, and integrative oncology can improve quality of life\, treatment delivery\, and clinical outcomes for people with cancer. Julie Gralow will discuss the role of exercise in oncology\, while Andreas Charalambous will examine how integrating symptom management into cancer care may contribute to improved survival. Matti Aapro and Karim Nagui will co-chair the webinar\, which will also include a discussion\, Q&A\, and closing remarks. The session is part of the SPCC Corporate Programme on Integrative Oncology. \nLogin for the Webinar.
URL:https://oncodaily.com/event/spcc-webinar-2026-550038
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/spcc-e1731076868159-800x477-1-1.webp
ORGANIZER;CN="Sharing Progress in Cancer Care (SPCC)":MAILTO:info@spcc.net
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;TZID=America/Halifax:20261007T183000
DTEND;TZID=America/Halifax:20261007T183000
DTSTAMP:20260826T122502Z
CREATED:20260826T122502Z
LAST-MODIFIED:20260826T122502Z
UID:10000958-1791397800-1791397800@oncodaily.com
SUMMARY:ESMO Deep Dive: The Evolving Landscape in Relapsed Ovarian Cancer 2026
DESCRIPTION:The ESMO Deep Dive: Gynaecological Cancers – The Evolving Landscape in the Treatment of Relapsed Ovarian Cancer 2026\, organized by the European Society for Medical Oncology (ESMO)\, will take place on October 7\, 2026\, at 6:30 PM CEST (8:30 PM AMT). \nThis live educational webinar will examine how new concepts and therapeutic strategies are reshaping the management of relapsed ovarian cancer\, with particular attention to evolving treatment classifications and the growing role of antibody–drug conjugates (ADCs). \nThe expert discussion will address how emerging therapies may be integrated and sequenced within current treatment pathways\, providing practical insights for clinicians managing patients with recurrent disease. Participants attending the live session can earn 2 ESMO-MORA Category 1 points.
URL:https://oncodaily.com/event/esmo-deep-dive-574943
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-26-2026-04_23_56-PM.webp
ORGANIZER;CN="European Society For Medical Oncology (ESMO)":MAILTO:esmo@esmo.org
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261008
DTEND;VALUE=DATE:20261010
DTSTAMP:20260720T151856Z
CREATED:20260720T151732Z
LAST-MODIFIED:20260720T151856Z
UID:10000804-1791417600-1791590399@oncodaily.com
SUMMARY:4th International Conference on Innovations and Advances in Cancer Research and Treatment - UICC
DESCRIPTION:The 4th International Conference\, on Innovations and Advances in Cancer Research and Treatment – Cancer 2026\, organized by Scitechseries\, will take place on 8–9 October 2026 at ANA Crowne Plaza Narita in Chiba\, Japan. \nUnder the theme “Empowering Global Collaboration in Cancer Care\,” the conference will bring together researchers\, oncologists\, geneticists\, engineers\, and other specialists to discuss advances in cancer research\, precision medicine\, emerging therapies\, and innovative technologies. The programme will include keynote lectures\, oral and poster presentations\, panel discussions\, and more than 20 thematic tracks. Accepted conference proceedings will be peer-reviewed and published in Archives in Oncology Research with DOI assignment. \n 
URL:https://oncodaily.com/event/4th-international-conference-on-innovations-546784
LOCATION:ANA Crowne Plaza Narita\, 68 Horinouchi\, Narita\, Chiba\, 286-0107\, Japan
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/ChatGPT-Image-Jul-20-2026-06_48_15-PM.webp
ORGANIZER;CN="Scitechseries":MAILTO:info@scitechseries.com
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261008
DTEND;VALUE=DATE:20261010
DTSTAMP:20260726T101122Z
CREATED:20260726T101122Z
LAST-MODIFIED:20260726T101122Z
UID:10000833-1791417600-1791590399@oncodaily.com
SUMMARY:Mammo 2026: Global Breast Cancer Virtual Congress
DESCRIPTION:The Mammo 2026 Global Breast Cancer Virtual Congress\, organized by OncoDaily\, will take place online on 8–9 October 2026. \nThe international congress will bring together leading breast cancer specialists to examine practical\, evidence-based approaches to screening\, early diagnosis\, risk stratification\, multidisciplinary treatment\, survivorship\, and the management of early-stage\, metastatic\, HER2-positive\, hormone receptor-positive\, and triple-negative breast cancer. \nKey topics will include antibody–drug conjugates\, endocrine therapy sequencing\, immunotherapy\, surgical de-escalation\, breast imaging\, cancer genetics\, circulating tumour DNA\, fertility preservation\, lifestyle interventions\, and precision oncology. Scientific leadership is provided by Giuseppe Curigliano\, Antonio Marra\, and Sara Tolaney. The programme is designed for medical\, surgical\, and radiation oncologists\, pathologists\, radiologists\, researchers\, and oncology trainees seeking a globally informed update on breast cancer care in 2026. \nRegister Now.
URL:https://oncodaily.com/event/mammo-2026-551235
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/07/IMG_7626-1.webp
ORGANIZER;CN="OncoDaily":MAILTO:info@oncodaily.com
LOCATION:
END:VEVENT
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261008
DTEND;VALUE=DATE:20261010
DTSTAMP:20260822T141250Z
CREATED:20260822T141250Z
LAST-MODIFIED:20260822T141250Z
UID:10000943-1791417600-1791590399@oncodaily.com
SUMMARY:2026 Advances in Prostate Cancer Management: A Multidisciplinary Approach
DESCRIPTION:The 2026 Advances in Prostate Cancer Management: A Multidisciplinary Approach course\, organized by Memorial Sloan Kettering Cancer Center (MSK)\, will take place on October 8–9\, 2026\, in New York City\, with both in-person and virtual participation available. \nThe two-day program will focus on the latest advances across the full continuum of prostate cancer care\, bringing together experts in urology\, medical oncology\, radiation oncology\, radiology\, and pathology. \nSessions will address patient evaluation and risk assessment\, active surveillance\, focal therapy\, surgery\, radiation therapy\, systemic treatment\, prevention and management of treatment-related side effects\, genomic testing\, biomarkers\, PSMA PET imaging\, and emerging approaches for localized and advanced prostate cancer. \nThe course is intended for urologists\, urologic oncologists\, medical and radiation oncologists\, pathologists\, radiologists\, and allied health professionals\, and participants will receive access after the course to recorded presentations and faculty slides.
URL:https://oncodaily.com/event/advances-in-prostate-cancer-572294
LOCATION:Mortimer B. Zuckerman Research Center\, 417 East 68th Street\, New York\, NY\, 10065\, United States
ATTACH;FMTTYPE=image/webp:https://oncodaily.com/pub/uploads/2026/08/ChatGPT-Image-Aug-22-2026-06_11_52-PM.webp
ORGANIZER;CN="Memorial Sloan Kettering Cancer Center (MSK)":MAILTO:international@mskcc.org
END:VEVENT
END:VCALENDAR